Glutathione 1500mg

Glutathione 1500mg is a tripeptide research material intended exclusively for laboratory, analytical, and scientific applications.

Glutathione consists of glutamate, cysteine, and glycine and is commonly represented as γ-glutamyl-cysteinyl-glycine. FDA’s substance database identifies glutathione with the molecular formula C₁₀H₁₇N₃O₆S and recognizes reduced L-glutathione among its synonyms. FDA also makes clear that inclusion in its substance database does not itself indicate regulatory approval.

Glutathione is widely investigated as part of intracellular redox and thiol chemistry and as a biochemical cofactor. In controlled research environments, it may be useful for studies involving:

• Cellular redox pathways
• Oxidative-stress research
• Thiol chemistry
• Glutathione-dependent enzyme systems
• Cellular antioxidant mechanisms
• Mitochondrial and metabolic research
• Protein and molecular interaction studies
• Biochemical assay development
• Analytical characterization
• Comparative cellular research

These descriptions refer to laboratory research functions and should not be interpreted as claims that a Glutathione 1500mg research product produces therapeutic or cosmetic benefits in humans.

Product Information

• Product: Glutathione
• Strength: 1500mg
• Classification: Tripeptide research material
• Components: Glutamate, cysteine, and glycine
• Molecular Formula: C₁₀H₁₇N₃O₆S
• Research Areas: Cellular redox, biochemical, metabolic, and oxidative-pathway research
• Intended Setting: Laboratory, analytical, and scientific research
• Supplier: Peptides R US

Research Use Only

This product is offered exclusively for legitimate laboratory, analytical, and scientific research purposes.

It is not intended for human or veterinary consumption or administration and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

No IV, injection, dosage, supplementation, cosmetic, therapeutic, or other human-use instructions are provided or implied.

This distinction is particularly important for glutathione. On August 27, 2026, FDA warned compounders against using dietary-supplement-grade glutathione to make injectable drugs after reports of adverse events associated with injectable products, including concerns involving endotoxin contamination.